{"Symbol": "AMRX", "AssetType": "Common Stock", "Name": "Amneal Pharmaceuticals, Inc. Class A Common Stock", "Description": "Amneal Pharmaceuticals, Inc. develops, licenses, manufactures, markets and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company is headquartered in Bridgewater, New Jersey.", "CIK": "1723128", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "HEALTHCARE", "Industry": "DRUG MANUFACTURERS - SPECIALTY & GENERIC", "Address": "400 CROSSING BOULEVARD, BRIDGEWATER, NJ, UNITED STATES, 08807", "OfficialSite": "https://www.amneal.com", "FiscalYearEnd": "December", "LatestQuarter": "2025-09-30", "MarketCapitalization": "4658858000", "EBITDA": "623809000", "PERatio": "1482", "PEGRatio": "None", "BookValue": "-0.348", "DividendPerShare": "None", "DividendYield": "None", "EPS": "0.01", "RevenuePerShareTTM": "9.4", "ProfitMargin": "0.002", "OperatingMarginTTM": "0.119", "ReturnOnAssetsTTM": "0.0679", "ReturnOnEquityTTM": "-8.81", "RevenueTTM": "2934959000", "GrossProfitTTM": "1093702000", "DilutedEPSTTM": "0.01", "QuarterlyEarningsGrowthYOY": "2.61", "QuarterlyRevenueGrowthYOY": "0.117", "AnalystTargetPrice": "15.2", "AnalystRatingStrongBuy": "3", "AnalystRatingBuy": "2", "AnalystRatingHold": "0", "AnalystRatingSell": "0", "AnalystRatingStrongSell": "0", "TrailingPE": "1482", "ForwardPE": "6.3", "PriceToSalesRatioTTM": "1.587", "PriceToBookRatio": "86.1", "EVToRevenue": "2.434", "EVToEBITDA": "12.86", "Beta": "1.348", "52WeekHigh": "15", "52WeekLow": "6.68", "50DayMovingAverage": "13.22", "200DayMovingAverage": "10.19", "SharesOutstanding": "314363000", "SharesFloat": "191236000", "PercentInsiders": "46.459", "PercentInstitutions": "49.547", "DividendDate": "None", "ExDividendDate": "None"}